Factory Supply High Quality 99% Purity Raw Material Bimatoprost Powder

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: SH500
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >98%
• Transport Package: Drum
• Specification: 1kg/Bag 25kg/Drum
• Trademark: Source Herb
• Origin: China
• Production Capacity: 500kg/Month

Product Description

Product Name:	Bimatoprost	Molecular formula:	C25H37NO4
molecular weight:	415.5656	CAS NO:	155206-00-1
Test quantity:	25kg	Batch Number:	SH20230110
Production date	10, JAN. 2023	Testing date	10, JAN. 2023
Country of origin	China

ITEM	SPECIFICATION	RESULT	TEST METHOD
Appearance	White powder	Complies	Visual
Odor & Taste	Characteristic	Complies	Organoleptic
Sieve Analysis	98% pass 80 mesh	Complies	80 Mesh Screen
Assay	>99%	99.3%	HPLC
Density	0.5-0.7g/ml	Complies
Loss on Drying	5% Max	0.13%	5G/105ºC/5hrs
Sulphated Ash	5% Max	0.07%	5G/525ºC/3hrs
Pesticides	<1ppm	Complies	Gas Chromatography
Heavy Metals	10ppm Max	Complies	Atomic Absorption
Arsenic (As)	NMT 2ppm	Complies	Atomic Absorption
Lead (Pb)	NMT 3ppm	Complies	Atomic Absorption
Total Plate Count	1000cfu/g Max	Complies	CP2010
Yeast & Mold	100cfu/g Max	Complies	CP2010
Salmonella	Negative	Negative	CP2010
E.Coli	Negative	Negative	CP2010
Aflatoxins B1	<2ug/kg	Negative	HPLC
Aflatoxins (B1,B2,G1,G2)	<4ug/kg	Negative	HPLC
Packing	25kg/drum, Packing in paper-drums and two plastic-bags inside.
Storage	Store in a well-closed container away from moisture.
Shelf Life	2 years if sealed and store away from direct sun light.
Expiration Date	2025- JAN.-09

Product Introduction:
Bimaprost is considered to be the most potent local anti glaucoma drug for lowering IOP at present, and is effective in normal people, POAG, and OHT patients. It is mainly used in POAG or OHT patients who cannot tolerate other IOP lowering drugs or are ineffective with other IOP lowering drugs.

Glaucoma is a class of ocular diseases caused by excessive intraocular pressure (IOP) and causing damage to the optic nerve. The main treatment goal is to prevent high intraocular pressure from damaging the optic nerve and causing visual loss. Currently, the treatment of glaucoma is aimed at reducing IOPo bimatoprost eye drops (0.03% bimatoprost, LumiganTM, Allergan Company), which are local ophthalmic preparations approved by the FDA in the United States in 2001. They contain 0.3 mg · mL-1 of bimatoprost, 0.05 mg · mL-1 of benzalkonium chloride, and have a pH value of 6.8 to 7.8, Belongs to synthetic prostaglandin F2 α Derivatives. Its IOP lowering effect is strong and has a long-term effect, and it is mainly used in clinical treatment of slow opening angle glaucoma (POAG) and high intraocular pressure (OHT). The chemical name of bimatriprost is (Z) - 7 - [(1R, 2R, 3R, 5S) - 3,5-dihydroxy - [1E, 3S] - 3-hydroxy-5-phenyl-1-pentenyl] cyclopentanyl] - 5-N-ethylheptaneamide, and the molecular formula is C25H37 NO4.

SOURCEHERB Advantage:
Hangzhou Source Herb Biotechnology Co., Ltd. is a biotechnology company located in Hangzhou, China, focusing on the research and development of natural plant extracts and functional ingredients, providing plant extracts, natural pigments, plant proteins and other products and technical services.

The company's products are widely used in health products, food, cosmetics, medicine, agriculture and other fields. The company has a professional research and development team, as well as modern production equipment and laboratories. The company is committed to research and develop green, natural and healthy products, and actively promote the development of health industry.

Hangzhou Source Herb Biotechnology Co., Ltd. focuses on technical innovation and quality control, and has passed ISO22000 quality management system certification and HACCP food safety management system certification to ensure product quality and safety. At the same time, the company also actively participates in social public welfare undertakings and pays attention to environmental protection and sustainable development.

Product function:
Bisoprostol reduces IOP by increasing aqueous outflow from the trabecular meshwork and uveoscleral channels, and reducing superficial scleral venous pressure. Studies by Brukker et al. have shown that intravenous administration of 0.03% bisoprostol in normal volunteers can reduce intraocular pressure by 20%, the tension resistance of aqueous humor outflow by 26%, and the surface resistance of aqueous humor outflow by 31%.

Packaging method:  MOQ:1KG/BAG  25KG/DRUM

Type of shipping: By DHL, FEDEX, By AIR , By SEA